1. Market Research
  2. > Cancer Industry

Lymphoma Industry, January 2017 Market Reports from Top Publishers

You might be interested in: Diagnostics, Cancer, Therapy, Leukemia, Cloud Computing, Pap Smear, Transplantation, Bone Marrow Transplant, Cancer Diagnostic, Nuclear Imaging Equipment, Nuclear Medicine, Blood Disease, Immunotherapy, Infectious Disease, Lung Cancer, Monoclonal Antibody.


 
1-10 of about 300 reports for Lymphoma

Purchase Reports From Reputable Market Research Publishers

 T-Cell Lymphomas-Pipeline Insights, 2017

T-Cell Lymphomas-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ T-Cell Lymphomas-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the T-Cell Lymphomas. The DelveInsight’sReport ...

Small lymphocytic lymphoma - Epidemiology Forecast To 2023

Small lymphocytic lymphoma - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Small lymphocytic lymphoma - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Small lymphocytic lymphoma in seven major markets (US, France, Germany, ...

 Lymphoblastic Lymphoma-Pipeline Insights, 2017

Lymphoblastic Lymphoma-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Lymphoblastic Lymphoma-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Lymphoblastic Lymphoma. The ...

 Cutaneous T-Cell Lymphoma-Pipeline Insights, 2017

Cutaneous T-Cell Lymphoma-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Cutaneous T-Cell Lymphoma-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Cutaneous T-Cell Lymphoma. ...

 B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2017

B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the B-Cell Non-Hodgkin Lymphoma. ...

 B-Cell Lymphomas-Pipeline Insights, 2017

B-Cell Lymphomas-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ B-Cell Lymphomas-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the B-Cell Lymphomas. The DelveInsight’sReport ...

 Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2017

Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Peripheral T-Cell ...

Hodgkin’s lymphoma (HL) - Epidemiology Forecast To 2023

Hodgkin’s lymphoma (HL) - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Hodgkin’s lymphoma (HL) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Hodgkin’s lymphoma (HL) in seven major markets (US, France, Germany, Italy, ...

 Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2017

Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Anaplastic ...

 Indolent Lymphoma-Pipeline Insights, 2017

Indolent Lymphoma-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Indolent Lymphoma-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Indolent Lymphoma. The DelveIn ...

About 6500 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Therapy Market and Lymphoma Statistics in the UK

  • July 2016
    182 pages
  • Therapy  

    Lymphoma  

    Chemotherapy  

  • United Kingdom  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.